Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.90p
   
  • Change Today:
      0.013p
  • 52 Week High: 2.61
  • 52 Week Low: 0.85
  • Currency: UK Pounds
  • Shares Issued: 416.44m
  • Volume: 266,688
  • Market Cap: £7.91m
  • RiskGrade: 328

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £28,281
Lisa Baderoon 583,963 £11,095
Tim Franklin 525,000 £9,975

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 41,620,407 £790,788
Luca & Associates AG 22,000,000 £418,000
Invesco Ltd 17,872,341 £339,574
Aviva Investors Global 11,285,180 £214,418
Alora Pharmaceuticals LLC 10,909,091 £207,273
M&G Investments 7,600,000 £144,400
Prudential plc 7,600,000 £144,400
Capital Income Builder 4,870,367 £92,537
Dr R Zimmer 4,551,553 £86,480
Odey Asset Management 3,433,319 £65,233
Rhone Trustees (Switzerland) SA 3,386,000 £64,334
Pictet Overseas Trust Corporation Limited 3,287,500 £62,462

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 1.90p
Change Today 0.013p
% Change 0.66 %
52 Week High 2.61
52 Week Low 0.85
Volume 266,688
Shares Issued 416.44m
Market Cap £7.91m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
72.98% below the market average72.98% below the market average72.98% below the market average72.98% below the market average72.98% below the market average
36% below the sector average36% below the sector average36% below the sector average36% below the sector average36% below the sector average
Price Trend
40.66% below the market average40.66% below the market average40.66% below the market average40.66% below the market average40.66% below the market average
12.00% above the sector average12.00% above the sector average12.00% above the sector average12.00% above the sector average12.00% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 09-Oct-2024

Time Volume / Share Price
16:17 20,000 @ 1.90p
16:13 3 @ 1.90p
16:01 53 @ 1.90p
16:01 53 @ 1.90p
16:00 55,214 @ 1.88p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page